DK0770613T3 - Substituerede imidazolidin-2,4-dion-forbindelser som immunmodulatorer - Google Patents

Substituerede imidazolidin-2,4-dion-forbindelser som immunmodulatorer

Info

Publication number: DK0770613T3
Authority: DK; Denmark
Prior art keywords: immunomodulators; dione compounds; substituted imidazolidine; imidazolidine; substituted
Prior art date: 1995-10-27

Application number

DK96116069T

Other languages

English (en)

Inventor

Oswald Dr Zimmer

Stephan Dr Wnendt

Horst Dr Boehlke

Kai Dr Zwingenberger

Cornelia Dr Geist-Rudolf

Original Assignee

Gruenenthal Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-10-27

Filing date

1996-10-08

Publication date

1999-12-13

1996-10-08 Application filed by Gruenenthal Gmbh filed Critical Gruenenthal Gmbh

1999-12-13 Application granted granted Critical

1999-12-13 Publication of DK0770613T3 publication Critical patent/DK0770613T3/da

Links

WJRBRSLFGCUECM-UHFFFAOYSA-N hydantoin Chemical class O=C1CNC(=O)N1 WJRBRSLFGCUECM-UHFFFAOYSA-N 0.000 title 1
239000002955 immunomodulating agent Substances 0.000 title 1
229940121354 immunomodulator Drugs 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Immunology (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Pain & Pain Management (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

DK96116069T 1995-10-27 1996-10-08 Substituerede imidazolidin-2,4-dion-forbindelser som immunmodulatorer DK0770613T3 (da)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
DE19540027A DE19540027A1 (de)	1995-10-27	1995-10-27	Substituierte Imidazolidin-2,4-dion-Verbindungen als pharmazeutische Wirkstoffe

Publications (1)

Publication Number	Publication Date
DK0770613T3 true DK0770613T3 (da)	1999-12-13

Family

ID=7775931

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK96116069T DK0770613T3 (da)	1995-10-27	1996-10-08	Substituerede imidazolidin-2,4-dion-forbindelser som immunmodulatorer

Country Status (22)

Country	Link
US (1)	US6004963A (da)
EP (1)	EP0770613B1 (da)
JP (1)	JPH09188677A (da)
KR (1)	KR100445539B1 (da)
CN (1)	CN1097050C (da)
AR (1)	AR004517A1 (da)
AT (1)	ATE181072T1 (da)
AU (1)	AU707751B2 (da)
CA (1)	CA2188908A1 (da)
CO (1)	CO4750655A1 (da)
DE (2)	DE19540027A1 (da)
DK (1)	DK0770613T3 (da)
ES (1)	ES2135148T3 (da)
GR (1)	GR3030558T3 (da)
HU (1)	HU222120B1 (da)
IL (1)	IL119488A (da)
MX (1)	MX9605023A (da)
PE (1)	PE20011055A1 (da)
PL (1)	PL184446B1 (da)
RU (1)	RU2163603C2 (da)
SI (1)	SI0770613T1 (da)
ZA (1)	ZA968956B (da)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE19732928C2 (de) *	1997-07-31	2000-05-18	Gruenenthal Gmbh	Verwendung substituierter Imidazolidin-2,4-dion-Verbindungen als Schmerzmittel
DE19917961A1 (de)	1999-04-21	2000-10-26	Degussa	Verfahren zur Herstellung von Aminosäurederivaten
US6350763B1 (en) *	1999-07-21	2002-02-26	Boehringer Ingelheim Pharmaceuticals, Inc.	Small molecules useful in the treatment of inflammation disease
CN1209358C (zh)	2000-05-31	2005-07-06	田边制药株式会社	αLβ2介导细胞粘连的抑制剂
SE0100902D0 (sv) *	2001-03-15	2001-03-15	Astrazeneca Ab	Compounds
SE0100903D0 (sv) *	2001-03-15	2001-03-15	Astrazeneca Ab	Compounds
US7354933B2 (en)	2003-01-31	2008-04-08	Aventis Pharma Sa	Cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors
FR2850652B1 (fr) *	2003-01-31	2008-05-30	Aventis Pharma Sa	Nouveaux derives d'uree cyclique, leur preparation et leur utilisation pharmaceutique comme inhibiteurs de kinases
US20050203156A1 (en) *	2004-03-12	2005-09-15	Wyeth	Hydantoins having RNase modulatory activity
EP1621535A1 (en) *	2004-07-27	2006-02-01	Aventis Pharma S.A.	Substituted cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors
EP1621539A1 (en) *	2004-07-27	2006-02-01	Aventis Pharma S.A.	Heterocycle -substituted cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors
EP1621536A1 (en) *	2004-07-27	2006-02-01	Aventis Pharma S.A.	Amino cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors
US7709517B2 (en)	2005-05-13	2010-05-04	The Regents Of The University Of California	Diarylhydantoin compounds
FR2896503B1 (fr) *	2006-01-23	2012-07-13	Aventis Pharma Sa	Nouveaux derives soufres d'uree cyclique, leur preparation et leur utilisation pharmaceutique comme inhibiteurs de kinases
FR2896504B1 (fr) *	2006-01-23	2012-07-13	Aventis Pharma Sa	Nouveaux derives d'uree cyclique, leur preparation et leur utilisation pharmaceutique comme inhibiteurs de kinases
AU2012241184B2 (en) *	2006-03-27	2016-01-07	The Regents Of The University Of California	Androgen receptor modulator for the treatment of prostate cancer and androgen receptor-associated diseases
AU2013205325B2 (en) *	2006-03-27	2016-03-24	The Regents Of The University Of California	Androgen receptor modulator for the treatment of prostate cancer and androgen receptor-associated diseases
AU2016201061B2 (en) *	2006-03-27	2017-03-02	The Regents Of The University Of California	Androgen receptor modulator for the treatment of prostate cancer and androgen receptor-associated diseases
LT2656842T (lt) *	2006-03-27	2016-09-26	The Regents Of The University Of California	Androgeno receptoriaus moduliatorius, skirtas prostatos vėžio ir su androgeno receptoriumi susijusių ligų gydymui
KR101456722B1 (ko) *	2006-03-29	2014-10-31	더 리전트 오브 더 유니버시티 오브 캘리포니아	디아릴티오히단토인 화합물
WO2008021337A1 (en)	2006-08-15	2008-02-21	Wyeth	Oxazinan-2-one derivatives useful as pr modulators
TW200815428A (en)	2006-08-15	2008-04-01	Wyeth Corp	Oxazolidone derivatives as PR modulators
WO2008021309A1 (en) *	2006-08-15	2008-02-21	Wyeth	Imidazolidin-2-one derivatives useful as pr modulators
US7649007B2 (en) *	2006-08-15	2010-01-19	Wyeth Llc	Oxazolidine derivatives as PR modulators
ES2400163T3 (es) *	2006-09-08	2013-04-08	Actelion Pharmaceuticals Ltd.	Derivados de piridil-3-ilo como agentes de inmunomodulación
TWI469971B (zh)	2007-10-26	2015-01-21	Univ California	二芳基乙內醯脲類化合物
EP2307379A2 (en) *	2008-06-27	2011-04-13	Novartis AG	Organic compounds
CN102439008B (zh)	2009-05-12	2015-04-29	杨森制药有限公司	1,2,4-三唑并[4,3-a]吡啶衍生物及其用于治疗或预防神经和精神病症的用途
WO2011103202A2 (en)	2010-02-16	2011-08-25	Aragon Pharmaceuticals, Inc.	Androgen receptor modulators and uses thereof
SG11201501870RA (en)	2012-09-26	2015-04-29	Aragon Pharmaceuticals Inc	Anti-androgens for the treatment of non-metastatic castrate-resistant prostate cancer
SG10201907684PA (en)	2013-01-15	2019-10-30	Aragon Pharmaceuticals Inc	Androgen receptor modulator and uses thereof
TWI726969B (zh)	2016-01-11	2021-05-11	比利時商健生藥品公司	用作雄性激素受體拮抗劑之經取代之硫尿囊素衍生物
AU2018351714A1 (en)	2017-10-16	2020-04-30	Aragon Pharmaceuticals, Inc.	Anti-androgens for the treatment of non-metastatic castration-resistant prostate cancer

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3382406D1 (de) *	1982-04-08	1991-10-17	Shell Int Research	Neue hydantoine, ihre herstellung und verwendung.
FR2537133A1 (fr) *	1982-12-07	1984-06-08	Rhone Poulenc Sante	Nouveaux derives de la (piperazinyl-1)-5 pyrrolidine, leur preparation et les medicaments qui les contiennent
US4746669A (en) *	1985-12-23	1988-05-24	Merck & Co., Inc.	Substituted thiazoles as immunoregulants
JPH02101065A (ja) *	1988-10-06	1990-04-12	Tanabe Seiyaku Co Ltd	イミダゾリン誘導体及びその製法
FR2656302B1 (fr) *	1989-12-22	1992-05-07	Roussel Uclaf	Nouveau procede de preparation de l'anandron et derives de l'anandron.
AU9030691A (en) *	1990-11-06	1992-05-26	Smithkline Beecham Corporation	Imidazolidinone compounds
IL110296A (en) *	1993-07-16	1999-12-31	Smithkline Beecham Corp	Imidazole compounds process for their preparation and pharmaceutical compositions containing them
DE19529425A1 (de) *	1995-08-10	1997-02-13	Dresden Arzneimittel	Neue, antikonvulsiv wirkende Imidazolin-2,4-dione, die in 1-Stellung einen orthosubstituierten Ar(alk)yl-Rest enthalten, und Verfahren zu deren Herstellung
US7466669B2 (en) *	2003-11-14	2008-12-16	Telefonaktiebolaget Lm Ericsson (Publ)	Reverse link scheduler for CDMA networks

1995
- 1995-10-27 DE DE19540027A patent/DE19540027A1/de not_active Withdrawn
1996
- 1996-09-26 PE PE1996000688A patent/PE20011055A1/es not_active Application Discontinuation
- 1996-10-04 CO CO96052910A patent/CO4750655A1/es unknown
- 1996-10-08 DK DK96116069T patent/DK0770613T3/da active
- 1996-10-08 AT AT96116069T patent/ATE181072T1/de not_active IP Right Cessation
- 1996-10-08 SI SI9630066T patent/SI0770613T1/xx not_active IP Right Cessation
- 1996-10-08 ES ES96116069T patent/ES2135148T3/es not_active Expired - Lifetime
- 1996-10-08 DE DE59602155T patent/DE59602155D1/de not_active Expired - Fee Related
- 1996-10-08 EP EP96116069A patent/EP0770613B1/de not_active Expired - Lifetime
- 1996-10-14 AU AU68181/96A patent/AU707751B2/en not_active Ceased
- 1996-10-16 AR ARP960104778A patent/AR004517A1/es unknown
- 1996-10-22 MX MX9605023A patent/MX9605023A/es unknown
- 1996-10-24 HU HU9602932A patent/HU222120B1/hu not_active IP Right Cessation
- 1996-10-24 JP JP8282701A patent/JPH09188677A/ja active Pending
- 1996-10-24 ZA ZA968956A patent/ZA968956B/xx unknown
- 1996-10-25 KR KR1019960048441A patent/KR100445539B1/ko not_active Expired - Fee Related
- 1996-10-25 CA CA002188908A patent/CA2188908A1/en not_active Abandoned
- 1996-10-25 RU RU96121181/04A patent/RU2163603C2/ru not_active IP Right Cessation
- 1996-10-25 PL PL96316706A patent/PL184446B1/pl not_active IP Right Cessation
- 1996-10-25 IL IL11948896A patent/IL119488A/xx not_active IP Right Cessation
- 1996-10-25 US US08/738,232 patent/US6004963A/en not_active Expired - Fee Related
- 1996-10-26 CN CN96121960A patent/CN1097050C/zh not_active Expired - Fee Related
1999
- 1999-06-17 GR GR990401639T patent/GR3030558T3/el unknown

Also Published As

Publication number	Publication date
JPH09188677A (ja)	1997-07-22
GR3030558T3 (en)	1999-10-29
EP0770613A1 (de)	1997-05-02
CO4750655A1 (es)	1999-03-31
AU707751B2 (en)	1999-07-22
EP0770613B1 (de)	1999-06-09
CN1097050C (zh)	2002-12-25
CN1152573A (zh)	1997-06-25
AU6818196A (en)	1997-05-01
KR970021076A (ko)	1997-05-28
CA2188908A1 (en)	1997-04-28
ZA968956B (en)	1997-05-29
ES2135148T3 (es)	1999-10-16
DE19540027A1 (de)	1997-04-30
HK1010367A1 (en)	1999-06-17
SI0770613T1 (en)	1999-10-31
ATE181072T1 (de)	1999-06-15
PE20011055A1 (es)	2001-12-29
MX9605023A (es)	1997-06-28
PL316706A1 (en)	1997-04-28
KR100445539B1 (ko)	2004-12-30
RU2163603C2 (ru)	2001-02-27
DE59602155D1 (de)	1999-07-15
IL119488A0 (en)	1997-01-10
US6004963A (en)	1999-12-21
IL119488A (en)	2001-01-11
HUP9602932A2 (hu)	1998-07-28
HU222120B1 (hu)	2003-04-28
HU9602932D0 (en)	1996-12-30
HUP9602932A3 (en)	1998-08-28
AR004517A1 (es)	1998-12-16
PL184446B1 (pl)	2002-10-31

Publication	Publication Date	Title
DK0770613T3 (da)	1999-12-13	Substituerede imidazolidin-2,4-dion-forbindelser som immunmodulatorer
DE59501802D1 (de)	1998-05-14	Substituierte 1H-3-Aryl-pyrrolidin-2,4-dion-Derivate
DK0894497T3 (da)	2004-05-03	Anvendelse af substituerede imidazolin-2,4-dion-forbindelser som smertestillende midler
BR9707786B1 (pt)	2009-12-01	composto.
EE04834B1 (et)	2007-06-15	Tselekoksiibiühendid
DZ1666A1 (fr)	2002-02-17	Composés hétérobicycliques.
ZA97175B (en)	1997-11-04	Novel substituted imidazole compounds.
FI972901L (fi)	1997-09-08	Määrätyt 1,4,5-trisubstituoidut imidatsoliyhdisteet, jotka ovat käyttökelpoisia sytokiineinä
NO996572D0 (no)	1999-12-30	Nye substituerte imidazolforbindelser
TR199501561A2 (tr)	1996-07-21	Imidazol türevleri.
BR9813566B1 (pt)	2010-07-13	composição biocida estabilizada contendo compostos de halopropinila.
DE69841138D1 (de)	2009-10-22	Imidazolderivate als mdr-modulatoren
NL1009835A1 (nl)	1999-02-22	Vloeibaar-kristallijne verbindingen.
DZ2583A1 (fr)	2003-02-22	Dérivés de 2-(4-aryl-ou hétéroaryl-pipérazine-1-ylméthyl)-1h-indole.
ZA98755B (en)	1999-07-29	Substituted hydroxy-anilino derivatives of cyclobutane-3,4-diones.
EP0668270A3 (fr)	1995-10-11	Dérivés de 2-imidazoline-5-ones fongicides.
BR9804301B1 (pt)	2008-11-18	compostos espirocÍclicos.
DE69628458D1 (de)	2003-07-03	25-hydroxy-16-ene-26,27-bishome-cholecalceriferol derivate
DE59811182D1 (de)	2004-05-19	Heterocyclische Verbindungen
NL1013652A1 (nl)	2000-05-25	Piperazinonderivaten.
DK0944601T3 (da)	2003-06-10	Heterocykliske quanidinylaminoforbindelser som alfa-2-adrenoceptoragonister
ITTO980741A0 (it)	1998-09-03	Procedimento di preparazione di composti del tipo arilamminoalchilidenemalonati.
TR199802196A3 (tr)	1999-10-21	Heterosiklik bilesimler.
FI973556A0 (fi)	1997-08-29	Foerfarande foer styrning av en debitering fraon en tjaenstfoerbrukare i ett telenaet
TR199600665A2 (tr)	1997-03-21	Asimetrik trifenilendioksazin bilesikleri.